The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...
The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Newronika announced today that it received FDA investigational device exemption (IDE) for its deep brain stimulation (DBS) system.
The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...
The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...
Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...
Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of the device.
What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results